Cipla has launched a mobile application, CipAir, to aid in asthma screening in India, aiming to address the country's high asthma burden and underdiagnosis. India's pharmaceutical industry is poised ...

In the 1960s, Cipla Limited got into the business of manufacturing Active Pharmaceutical Ingredients (APIs). This was a significant step towards the bulk production of medicine in the country.

Cipla Limited is an India-based global pharmaceutical company. The Company is engaged in manufacturing, developing and marketing a wide range of branded and generic formulations and Active ...

Cipla Ltd is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and Active ...

New Delhi: In line with the 'Not of Standard Quality' data provided by states, the apex drug regulatory body, the Central ...

There has been a lot of buzz over the regulation of dietary or nutritional supplements. But do you even need them?

Cipla's shares are currently priced at Rs 1439.65, reflecting a modest rise of 0.82%. The 7-day simple moving average is Rs 1475.93. Cipla is currently valued at Rs 1437.65, with a daily increase of 0 ...

Cipla reported a net profit of ₹1,303 crore, marking a 15% increase compared to the same period last year.

Bonus Oct 18, 1999 Nov 05, 1999 Oct 07, 1999 Bonus Ratio: 2 share(s) for every 1 shares held Rights Feb 03, 1995 Mar 02, 1995 May 03, 1995 Rights ratio: 4 share for every 50 held at a price of Rs ...

Return on investment - most recent fiscal year 16.16 ...